NASDAQ:OTIC
Delisted
Otonomy Stock News
$0.0085
+0 (+0%)
At Close: Jul 11, 2023
Why Is Otonomy (OTIC) Stock Up 97% Today?
12:27pm, Tuesday, 29'th Nov 2022
Otonomy (NASDAQ: OTIC ) stock is on the move Tuesday despite a lack of news from the biopharmaceutical company. Instead, it looks like traders have latched onto OTIC stock as the next big short squeez
Best Penny Stocks To Buy? 7 To Watch Under $1 Right Now
12:22pm, Tuesday, 15'th Nov 2022
Penny stocks to buy for under $1 but are they worth the risk? The post Best Penny Stocks To Buy?
These Were the Five Best and Worst Performing Healthcare Stocks in Q3 2022
09:21pm, Monday, 24'th Oct 2022
The healthcare industry is now starting to shift its focus away from the coronavirus pandemic to work on its core activities.
Otonomy, Inc. (OTIC) CEO Dave Weber on Q2 2022 Results - Earnings Call Transcript
08:18pm, Monday, 25'th Jul 2022
Otonomy, Inc. (NASDAQ:OTIC ) Q2 2022 Earnings Conference Call July 25, 2022 4:30 PM ET Company Participants Robert Uhl - Managing Director, ICR Westwicke Dave Weber - Chief Executive Officer, Presiden
Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update
07:30am, Monday, 18'th Jul 2022
SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it wil
Otonomy, Inc. (OTIC) CEO Dr. David Weber on Q1 2022 Results - Earnings Call Transcript
10:21pm, Monday, 09'th May 2022
Otonomy, Inc. (NASDAQ:OTIC ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Robert Uhl - IR David Weber - President, CEO and Director Paul Cayer - Chief Financial & Busin
Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate Update
07:30am, Monday, 02'nd May 2022
SAN DIEGO, May 02, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will
Otonomy: Hearing Loss And Tinnitus Data In 2022
12:23pm, Monday, 04'th Apr 2022
Data for OTO-413 in hearing loss is due early in Q2 2002.
Otonomy, Inc. 2021 Q4 - Results - Earnings Call Presentation
06:20am, Tuesday, 01'st Mar 2022 Seeking Alpha
Otonomy (OTIC) Q4 2021 Earnings Call Transcript
02:00am, Tuesday, 01'st Mar 2022 The Motley Fool
OTIC earnings call for the period ending December 31, 2021.
Otonomy, Inc. (OTIC) CEO Dr. David Weber on Q4 2021 Results - Earnings Call Transcript
12:41am, Tuesday, 01'st Mar 2022 Seeking Alpha
Otonomy GAAP EPS of -$0.20 misses by $0.02
09:33pm, Monday, 28'th Feb 2022 Seeking Alpha
Otonomy press release (NASDAQ:OTIC): Q4 GAAP EPS of -$0.20 misses by $0.02.
Otonomy Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
09:27pm, Monday, 28'th Feb 2022 GlobeNewswire
Conference call and webcast today at 4:30 p.m. ET
Otonomy to Participate in Two Upcoming Investor Conferences
07:30am, Monday, 28'th Feb 2022
SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that ma
Otonomy to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update
12:30pm, Thursday, 17'th Feb 2022 GlobeNewswire
SAN DIEGO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will report financial results for the fourth quarter and full year 2021 and provide a corporate update at 4:30 p.m. ET on February 28, 2022.
